ArticleBreast care (Basel, Switzerland)2017

Is There Still a Role for First-Line Single Agent Endocrine Therapy in HR+ and HER2- Advanced Breast Cancer?

Luca Malorni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.